CAMK2G and major depressive disorder: Figure 9 shows that CUMS reduced p-CaMK II in the hippocampus, and that HMF treatments suppressed this phenomenon. These results in combination with our previous findings [16] strongly indicate that HMF is a novel antidepressant based on the “BDNF theory of depression”.